Miracle Mile Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History

Miracle Mile Advisors’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.13M	Buy	10,324 +806	+8%	+$357K	0.06%	203
2026 Q1	$4.25M	Sell	9,518 -316	-3%	-$147K	0.06%	208
2025 Q4	$4.46M	Buy	9,834 +759	+8%	+$327K	0.06%	202
2025 Q3	$3.55M	Buy	9,075 +1,040	+13%	+$435K	0.05%	222
2025 Q2	$3.58M	Buy	8,035 +1,467	+22%	+$676K	0.06%	194
2025 Q1	$3.18M	Buy	6,568 +785	+14%	+$366K	0.06%	169
2024 Q4	$2.33M	Sell	5,783 -33	-0.6%	-$15.3K	0.05%	209
2024 Q3	$2.7M	Buy	5,816 +756	+15%	+$363K	0.06%	162
2024 Q2	$2.37M	Buy	5,060 +590	+13%	+$256K	0.06%	172
2024 Q1	$1.87M	Buy	4,470 +1,479	+49%	+$625K	0.05%	191
2023 Q4	$1.22M	Buy	+2,991	New	+$1.1M	0.03%	224

Other funds holding VRTX

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Miracle Mile Advisors's VRTX Position: Q2 2026 in Review

Miracle Mile Advisors increased its Vertex Pharmaceuticals (VRTX) stake by 8.5% in Q2 2026, buying an estimated $357K and bringing the position to 10,324 shares worth $5.13M. The position accounts for 0.06% of the portfolio, ranked #203.

Miracle Mile Advisors first reported a position in VRTX in Q4 2023 and has held it in 11 quarters since. 1,757 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

Miracle Mile Advisors held 10,324 shares of Vertex Pharmaceuticals worth $5.13M as of Q2 2026.
Miracle Mile Advisors bought 806 Vertex Pharmaceuticals shares in Q2 2026, an estimated $357K.
Vertex Pharmaceuticals made up 0.06% of Miracle Mile Advisors's portfolio in Q2 2026, its #203 holding.
Miracle Mile Advisors first reported a position in Vertex Pharmaceuticals in Q4 2023 and has held it in 11 quarters since.
1,757 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Miracle Mile Advisors's 13F filing for Q2 2026, filed 22 Jul 2026.